Skip to main content


480 Biomedical Awarded $1 Million Phase II NHLBI Contract to Advance Bioresorbable Scaffold for Pediatric Pulmonary Artery Stenosis

July 9, 2014

Proprietary bioresorbable scaffold technology addresses a critical challenge in treating pediatric cardiovascular conditions

View press release


BSI Certificate Awarded

December 11, 2013

480 Biomedical receives its certificate of registration to ISO13485: 2003 for its Quality Management System

View certificate

VIVA 2012

October 10, 2012

480 Biomedical Announces Initial Observations from OCT Sub-Study of the STANCE Trial Evaluating the First Self-Expanding Bioresorbable Scaffold for Superficial Femoral Artery Disease

View press release

Products presented in this website are not available for sale or distribution and are limited to clinical investigational use only.